Value of Molecular Typing Combined with Integrated Positron Emission Tomography/Magnetic Resonance Imaging in Risk Stratification of Endometrial Cancer
DOI: https://doi.org/10.2147/ijwh.s444046
2024-05-17
International Journal of Women s Health
Abstract:Xuan Wang, 1, &ast Yi-Fan Wang, 2, &ast Shi-Jun Wang 1 1 Department of Gynecology, Xuanwu Hospital Capital Medical University, Beijing, 100053, People's Republic of China; 2 Department of Gynecology, Beijing Youan Hospital Capital Medical University, Beijing, 100069, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shi-Jun Wang, Department of Gynecology, Xuanwu Hospital Capital Medical University, No. 45 of Changchun Street, Xicheng District, Beijing, 100053, People's Republic of China, Tel + 86 15001119089, Email Objective: In this study, we investigated the value of molecular typing combined with integrated positron emission tomography (PET)/magnetic resonance imaging (MRI) semi-quantitative indices in endometrial cancer risk stratification. Methods: A retrospective study was conducted on 86 patients who were pathologically diagnosed with endometrial cancer and underwent surgical treatment after curettage at the Department of Obstetrics and Gynecology, Xuanwu Hospital, Capital Medical University between January 2017 and March 2023. Prior to surgery, each patient underwent integrated PET/MRI examination. The postoperative samples were subjected to pathological diagnosis, immunohistochemistry, and POLE gene sequencing. The differences in clinicopathological features between the four molecular subtypes and the differences in integrated PET/MRI semi-quantitative indexes (SUV max, ADC min) between the four molecular subtypes were analyzed. The cutoff value of molecular typing combined with integrated PET/MRI semi-quantitative indices for endometrial cancer risk stratification was determined. Results: There were statistically significant differences in pathological types and tumor grades among the four molecular subtypes of endometrial cancer. The values of the four integrated PET/MRI semi-quantitative indices (SUV max and ADC min) of the molecular subtypes were statistically different. The SUV max was greater in the p53abn mutation group than in the POLE mutation group ( P < 0.05). The ADC minimum of the POLE mutation group and the MMR-d group was lower than the NSMP group ( P Conclusion: Molecular typing combined with integrated PET/MRI semi-quantitative indicators is useful to achieve risk stratification in patients diagnosed with endometrial cancer and guide individualized treatment. Keywords: endometrial cancer, integrated PET/MRI, individualized treatment, molecular typing Endometrial cancer (EC) is a malignant tumor originating from the endometrium, that is more prevalent in elderly women. The incidence of endometrial cancer in malignant tumors of the female genital tract can reach 20%–30%. With the evolution of the modern lifestyle and the extension of life expectancy, the global incidence of EC has been increasing annually and has become prevalent in younger women over the past two decades. 1 Patients diagnosed with endometrial cancer are typically treated with surgery. The scope of surgery is determined by a comprehensive preoperative evaluation. Diagnostic curettage is performed to determine the pathological diagnosis to obtain histological subtypes and grades, and iconography is used for preoperative staging. With the development of precision medicine, the standard pathomorphological classification is no longer adequate for clinical diagnosis and treatment. Along with the advancement of genomics research, molecular classification of endometrial cancer is being carried out to provide more tumor biological information. In 2013, the Cancer Genome Atlas Program (TCGA) conducted a large-scale, comprehensive, and integrated genomic analysis of 373 cases of endometrial cancer, which was divided into four molecular subtypes based on different clinicopathological and molecular characteristics, namely POLE exonuclease domain mutations (POLE) exonuclease domain mutations (POLE mut), microsatellite instability-high mutation (MSI-H), copy number abnormalities-low (CN-L), and copy number abnormalities-high (CN-H). Among these four molecular subtypes, the POLE mutant type had the best prognosis, followed by the CN-L type, MSI-H type, and CN-H type, which had the worst prognosis. 2 Nevertheless, the widespread clinical utilization of TCGA molecular typing diagnostic technology has been impeded by its high cost. In 2015, McConechy et al 3 sought to simplify the TCGA detection method. They accomplished this by employing immunohistochemical staining for mismatch repair (MMR) proteins and p53 protein, as well as sequencing the POLE gene. This simplified approach was extended beyond endometrial cancer to include non-endometrioid adenocarcinoma. As a result -Abstract Truncated-
obstetrics & gynecology